Menopause hormonal therapy in women with systemic lupus erythematosus

Abstract

Menopause hormonal therapy did not alter disease activity during 2 years of treatment. However, an apparently increased risk of thrombosis seems to be a real threat in women with SLE who receive menopausal hormone therapy.